Drugs to avoid

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 15, Issue 6, 2001, Pages 971-986

  Shehata, Hassan A ^a   Nelson Piercy, Catherine ^b  

^a ST HELIER HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Drugs; Fetus; Pregnancy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTHELMINTIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CARDIOVASCULAR AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COLCHICINE; CYCLOOXYGENASE 2 INHIBITOR; CYTOTOXIC AGENT; ETRETIN; GRISEOFULVIN; HORMONE; ISOTRETINOIN; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT; RETINOID; RETINOL DERIVATIVE; TERATOGENIC AGENT; TETRACYCLINE; THALIDOMIDE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN; WARFARIN; ANTIINFECTIVE AGENT; DRUG;

ANXIETY; AUTOIMMUNE DISEASE; BIRTH DEFECT; BLOOD CLOTTING DISORDER; CANCER; CARDIOVASCULAR DISEASE; CONGENITAL MALFORMATION; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RESEARCH; DRUG USE; ENDOCRINE DISEASE; EPIDEMIOLOGICAL DATA; EPILEPSY; FEMALE; FETUS; FETUS DEVELOPMENT; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; INFECTION; INFLAMMATION; MEDICAL INFORMATION; MENTAL DISEASE; MYCOSIS; ORGANOGENESIS; PARENTAL BEHAVIOR; PREGNANCY; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TERATOGENESIS; TERATOGENICITY; TREATMENT INDICATION; WORM INFECTION; FETOMATERNAL TRANSFUSION; PREGNANCY COMPLICATION; PRENATAL EXPOSURE;

ABNORMALITIES, DRUG-INDUCED; ANTI-BACTERIAL AGENTS; CARDIOVASCULAR AGENTS; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0035676277     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2001.0241     Document Type: Article

References (72)

1. Medication in early pregnancy: Prevalence of use and relationship to maternal characteristics
2. Prescribing in pregnancy. General principles
3. Epidemiology of drugs taken by pregnant women: Drugs that may affect the fetus adversely
4. Drugs taken by mothers in the puerperium: Inpatient survey in Northern Ireland
5. Investigations into the influence of posture on renal plasma flow and glomerular filtration rate during late pregnancy
6. Major and minor malformations in newborns and infants up to one year of age
7. The incidence of hereditary disease in man
8. General principles
9. Drugs in pregnancy
10. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice
11. Low-dose thalidomide seems to be effective in multiple myeloma
12. American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus
13. Thalidomide responsiveness in an infant with Behçet's syndrome
14. Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre
15. Teratogenic effects of retinoic acid in pigtail monkeys (Macoca nemestrina) I. General features
16. Retinoic acid embryopathy
17. Lithium, Ebstein's anomaly, and other congenital heart defects
18. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester
19. Treatment of inflammatory rheumatic disorders in pregnancy: What are the safest treatment options?
20. Effects of immunosuppressive drugs during pregnancy
21. Current treatment practice in immunosuppression
22. Children of renal transplant recipient mothers
23. Connective tissue disorders and pregnancy. Recommendations for prescribing
24. Maternal and fetal sequelae of anticoagulation during pregnancy
25. Hazards of oral anticoagulants during pregnancy
26. Dose dependent fetal complications of warfarin in pregnant women with mechanical heart valves
27. Epilepsy and pregnancy
28. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid
29. Teratogen update: Valproic acid
30. Spina bifida in infants of women treated with carbamazepine during pregnancy
31. The fetal hydantoin syndrome
32. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy
33. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: A report of a collaborative study group in Japan
34. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
35. Nonsteroidal anti-inflammatory drugs during pregnancy
36. Effects of acetylsalicyclic-acid ingestion on maternal and neonatal hemostasis
37. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin
38. Neonatal outcome after indomethacin treatment for preterm labor
39. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic
40. Colchicine: A state-of-the-art review
41. Colchicine: 1998 update
42. Can tetracycline-induced fatty liver in pregnancy be attributed to choline deficiency?
43. Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline
44. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin
45. Placental transfer of enrofloxacin and ciprofloxacin in rabbits
46. Safety of the new quinolones in pregnancy
47. Folic acid antagonists during pregnancy and the risk of birth defects
48. Effect of ketoconazole on placental aromatase, 3 beta-hydroxysteroid dehydrogenase-isomerase and 17 beta-hydroxysteroid dehydrogenase
49. Cushing's syndrome in pregnancy treated by ketoconazole: Case report and review of the literature
50. Terbinafine: An update
51. Beta-blockers in pregnancy
52. Treatment of cardiovascular disease
53. Neonatal anuria with maternal angiotensin-converting enzyme inhibition
54. Pregnancy outcome with ACE-inhibitor use in early pregnancy
55. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995
56. Possible contraindication of spironolactone during pregnancy
57. Lack of effect of spironolactone on male genital development
58. Effects of amiodarone on thyroid function
59. Amiodarone and the thyroid
60. Neurodevelopment after in utero amiodarone exposure
61. Transient neonatal hypothyroidism after gestational exposure to amiodarone: A follow-up of two cases
62. Treating thyrotoxicosis in pregnant or potentially pregnant women
63. Virilization of the female fetus with maternal danazol exposure
64. Lithium: A review of its pharmacokinetics, health effects, and toxicology
65. Association of maternal lithium exposure and premature delivery
66. Lithium treatment of women during pregnancy and the post-delivery period
67. Lithium and pregnancy
68. A reevaluation of risk of in utero exposure to lithium
69. Bipolar illness, lithium prophylaxis, and pregnancy
70. Identifying abnormalities